The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen

Episode notes

Send us Fan Mail What if I told you there is a major genetic risk factor for heart attacks and strokes that affects roughly one in five people worldwide - but most people have never heard of it, and it isn't measured on a standard cholesterol test? Today we're exploring Lp(a), the hidden cardiovascular risk factor that could reshape the future of heart disease prevention. Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P., is Senior Vice President and Chief Medical Officer of Amgen ( ). Dr. Burton has built one of the most remarkable careers in modern medicine and biotechnology. After training as a physician and cardiovascular surgeon in the United Kingdom and earning a Ph.D. in molecular and cellular biology from Imperial College London, he transitioned into the biotechnology industry, where he has spent more than two decades leading the development of innovative medicines across cardiovascular disease, oncology, infectious disease, metabolic disorders and RNA therapeutics. Before returning to Amgen as Chief Medical Officer in 2023, Dr.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• How Healthcare Moves from Reactive Care to Preventive with Ray PawlickiBiology Matters · on Precision medicine83 / 100
• MDVIP's New CMO Dr. Jeffrey Lin on What Sustainable Practice Actually Looks LikeThe DocPreneur Leadership Podcast · on cardiology76 / 100
• Healthcare AI Is Failing And the Fix Isn't More DataSaaS That App · on Precision medicine73 / 100
• The Evolving Landscape of Physician Practice Acquisitions with Holly Buckley of McGuireWoods LLP 6-25-26Becker Private Equity & Business Podcast · on cardiology65 / 100
• Longevity Is the New Wealth: Inside Fountain Life's Vision with Dr. William KappEntrepreneurs on Fire · on Precision medicine60 / 100
• Solving Patient Matching in Rare Disease TrialsP4A Let's Talk Rare: The Life Science Podcast · on Precision medicine56 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton